Experiment 637571
Worktypes
Compounds isolated
Details
| Property | Value |
|---|---|
| Pharmacology | |
| Administration route | ORAL |
| Organism | Empty organism |
| Citation | LIRUSSI,F: OKOLICSANYI,L:. (1992). CYTOPROTECTION IN THE NINETIES: EXPERIENCE WITH URSODEOXYCHOLIC ACID AND SILYMARIN IN CHRONIC LIVER DISEASE.. 80(1/4) |
| Amount utilized | |
| Compound isolated | |
| Disease | A RANDOMIZED CONTROLLED CROSS-OVER STUDY OF SILYMARIN AND URSODEOXYCHOLIC ACID FOR 6 MONTHS. SILYMARIN TREATMENT CAUSED A 15% AND 23% DECREASE OF SERUM AST AND ALT. IT WAS CONCLUDED THAT BOTH UDCA AND SILYMARIN SEEM SAFE AND BENEFICIAL IN ACTIVE CIRRHOSIS OF THE LIVER. |
| Dose amount | 420.0 MG |
| Number | 1 |
| Qualitative result | ACTIVE |
| Animal | HUMAN ADULT |
| Per unit | DAY |
| Dose expression | DOSE |
| Gender | GIVEN TO BOTH SEXES |